Heterogeneity in motoneuron disease

[1]  Yasushi Hiraoka,et al.  Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde Transport , 2003, Science.

[2]  H. Hartung,et al.  Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. , 2003, American journal of human genetics.

[3]  J. Shefner,et al.  Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy , 1999, Neurology.

[4]  Hynek Wichterle,et al.  Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons , 2007, Nature Neuroscience.

[5]  J. Julien,et al.  Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase , 2003, Neurobiology of Disease.

[6]  L. Greensmith,et al.  A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice , 2005, The Journal of cell biology.

[7]  A. Musarò,et al.  Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model , 2005, The Journal of cell biology.

[8]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[9]  U. Monani,et al.  Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. , 2004, The Journal of clinical investigation.

[10]  D. Brooks,et al.  Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS , 2007, Neurology.

[11]  W. Robberecht,et al.  The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[12]  J. Collinge,et al.  ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) , 2006, Neurology.

[13]  A. Lengeling,et al.  Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse , 2005, Nature Genetics.

[14]  N. Hirokawa,et al.  Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.

[15]  Kevin Eggan,et al.  Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model , 2007, Nature Neuroscience.

[16]  J. Thevelein,et al.  Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy , 2006, Nature Genetics.

[17]  J. Zhu,et al.  Amyotrophic Lateral Sclerosis 2-Deficiency Leads to Neuronal Degeneration in Amyotrophic Lateral Sclerosis through Altered AMPA Receptor Trafficking , 2006, The Journal of Neuroscience.

[18]  Robert H. Brown,et al.  Amyotrophic Lateral Sclerosis-Associated SOD1 Mutant Proteins Bind and Aggregate with Bcl-2 in Spinal Cord Mitochondria , 2004, Neuron.

[19]  P. Hiesinger,et al.  Drosophila VAP-33A Directs Bouton Formation at Neuromuscular Junctions in a Dosage-Dependent Manner , 2002, Neuron.

[20]  S. Reske,et al.  Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD , 2005, Annals of neurology.

[21]  B. Giraudeau,et al.  SMN1 gene, but not SMN2, is a risk factor for sporadic ALS , 2006, Neurology.

[22]  E. Bertini,et al.  Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. , 2002, American journal of human genetics.

[23]  M. Pericak-Vance,et al.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A , 2004, Nature Genetics.

[24]  G. Kollias,et al.  Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.

[25]  E. Rugarli,et al.  Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. , 2004, Human molecular genetics.

[26]  E. Rugarli,et al.  Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia. , 2005, The Journal of clinical investigation.

[27]  J. Julien,et al.  Deregulation of Cdk5 in a Mouse Model of ALS Toxicity Alleviated by Perikaryal Neurofilament Inclusions , 2001, Neuron.

[28]  J. D. Macklis,et al.  IGF-I specifically enhances axon outgrowth of corticospinal motor neurons , 2006, Nature Neuroscience.

[29]  F. Gage,et al.  Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.

[30]  A. Sik,et al.  Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis , 2006, Nature Neuroscience.

[31]  D. Turnbull,et al.  Motor neuron disease in a patient with a mitochondrial tRNAIle mutation , 2006, Annals of neurology.

[32]  J. Sanes,et al.  A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis , 2005, The Journal of comparative neurology.

[33]  P. Carmeliet,et al.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model , 2004, Nature.

[34]  W. Robberecht,et al.  The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis. , 2006, Archives of neurology.

[35]  A. Pestronk,et al.  Altered Axonal Mitochondrial Transport in the Pathogenesis of Charcot-Marie-Tooth Disease from Mitofusin 2 Mutations , 2007, The Journal of Neuroscience.

[36]  K. Fischbeck,et al.  Functional Analyses of Glycyl-tRNA Synthetase Mutations Suggest a Key Role for tRNA-Charging Enzymes in Peripheral Axons , 2006, The Journal of Neuroscience.

[37]  A. Dürr,et al.  Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. , 2002, American journal of human genetics.

[38]  A. Ludolph,et al.  Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS , 2004, Neurology.

[39]  L. Greensmith,et al.  Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model , 2005, Nature Medicine.

[40]  G. Forster,et al.  Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS , 2003, Neurology.

[41]  Christoph Schmitz,et al.  Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS , 2005, Nature Neuroscience.

[42]  A. Parsadanian,et al.  Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS , 2007, Experimental Neurology.

[43]  Michael Sendtner,et al.  Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches , 2002, Nature Neuroscience.

[44]  C. Lorson,et al.  Survival Motor Neuron Function in Motor Axons Is Independent of Functions Required for Small Nuclear Ribonucleoprotein Biogenesis , 2006, The Journal of Neuroscience.

[45]  K. Broadie,et al.  The Hereditary Spastic Paraplegia Gene, spastin, Regulates Microtubule Stability to Modulate Synaptic Structure and Function , 2004, Current Biology.

[46]  Shin J. Oh,et al.  Mutant dynactin in motor neuron disease , 2003, Nature Genetics.

[47]  S. Mckercher,et al.  Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.

[48]  Pico Caroni,et al.  Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF , 2006, Nature Neuroscience.

[49]  K. Fischbeck,et al.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. , 2003, American journal of human genetics.

[50]  N. Hirokawa,et al.  Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. , 2001, Cell.

[51]  C. Donadoni,et al.  Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. , 2004, Brain : a journal of neurology.

[52]  Jean-Pierre Julien,et al.  Transgenic mouse models of amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[53]  L. H. van den Berg,et al.  Spastin mutations in sporadic adult‐onset upper motor neuron syndromes , 2005, Annals of neurology.

[54]  S. Przedborski,et al.  The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice , 2006, Proceedings of the National Academy of Sciences.

[55]  S. Blanchard,et al.  Alsin/Rac1 signaling controls survival and growth of spinal motoneurons , 2006, Annals of neurology.

[56]  V. Meininger,et al.  A Frameshift Deletion in Peripherin Gene Associated with Amyotrophic Lateral Sclerosis* , 2004, Journal of Biological Chemistry.

[57]  P. Carmeliet,et al.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.

[58]  T. Wienker,et al.  Mutations in the gene encoding immunoglobulin μ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1 , 2001, Nature Genetics.

[59]  E. Simpson,et al.  Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[61]  M. Pericak-Vance,et al.  A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). , 2002, American journal of human genetics.

[62]  E. Rugarli,et al.  The m-AAA Protease Defective in Hereditary Spastic Paraplegia Controls Ribosome Assembly in Mitochondria , 2005, Cell.

[63]  J. Trojanowski,et al.  Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations , 2007, Annals of neurology.

[64]  S. Ennis,et al.  ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis , 2006, Nature Genetics.

[65]  W. Robberecht,et al.  GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[66]  G. Skibinski.  Mutations in the ESCRTIII endosomal complex protein CHMP2B associate with frontotemporal dementia , 2005 .

[67]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[68]  E. Fuchs,et al.  BPAG1n4 is essential for retrograde axonal transport in sensory neurons , 2003, The Journal of cell biology.

[69]  Noah W. Gray,et al.  Alsin Is a Rab5 and Rac1 Guanine Nucleotide Exchange Factor* , 2004, Journal of Biological Chemistry.

[70]  M. Cudkowicz,et al.  Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene , 1998, Annals of neurology.

[71]  A. F. Soleng,et al.  A thorny question: how does activity maintain dendritic spines? , 1999, Nature Neuroscience.